[CAS NO. 1884220-36-3]  SBI-0206965

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1884220-36-3]

Store
Catalog
SLK-S7885
Brand
Selleck
CAS
1884220-36-3

DESCRIPTION [1884220-36-3]

Overview

MDLMFCD29472244
Molecular Weight489.32
Molecular FormulaC21H21BrN4O5
SMILESO=C(NC)C1=CC=CC=C1OC2=NC(NC3=CC(OC)=C(OC)C(OC)=C3)=NC=C2Br

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.0437 mL10.2183 mL20.4365 mL
5 mM0.4087 mL2.0437 mL4.0873 mL
10 mM0.2044 mL1.0218 mL2.0437 mL
50 mM0.0409 mL0.2044 mL0.4087 mL

Description

SBI-0206965 is a highly selective autophagy kinase inhibitor with of 108 nM, about 7-fold selectivity over ULK2. SBI-0206965 inhibits and enhances in human glioblastoma and lung cancer cells.

Targets

ULK1 [1]
(Cell-free assay)
ULK2 [1]
(Cell-free assay)
108 nM711 nM

In vitro

In HEK293T transfected with WT or KI Myc-tagged ULK1 and WT Vps34, SBI-0206965 inhibits Ser249 phosphorylation of overexpressed Vps34 and Beclin1 Ser15 phosphorylation. SBI-0206965 suppresses autophagy induced by mTOR inhibition in A549 cells, and prevents ULK1-dependent cell survival in WT MEFs. In addition, SBI-0206965 also synergizes with mTOR inhibition to induce cancer cell death.